In December, we welcomed 21 new analysts to Seeking Alpha. This article showcases their stock picks and investment strategies ...

Partnership has already generated high-quality, AI-ready data in less than three months MOUNTAIN VIEW, CA / / January 8, 2026 / AbTherx today announced a therapeutic antibody discovery and ...

True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...

Bluetti's Elite 100 V2 uses renewable polycarbonate housing that cuts CO2 emissions by over 20% compared to conventional ...

Genprex Inc. has released preliminary in vivo proof-of-concept data for GPX-002, the company’s diabetes gene therapy drug candidate, in a nonhuman primate (NHP) model of type 2 diabetes and in a mouse ...